Free Corporate Rating

Free Corporate Rating

Discover how companies are aligning with the Paris Agreement’s goal of limiting global warming to 2°C. This tool provides you with up-to-date climate ratings, reflecting a company’s progress and commitment to sustainable practices. Whether you're an investor, policymaker, or eco-conscious consumer, our platform simplifies your search for transparent, data-driven insights on corporate climate performance.
Start exploring now and make informed decisions for a sustainable future !

VERTEX PHARMACEUTICALS INCORPORATED

Health Care

ISIN

US92532F1003

LEI

54930015RAQRRZ5ZGJ91

Description

Vertex Pharmaceuticals, Inc. is a biotechnology company that develops and commercializes innovative medicines to treat serious diseases. It focuses on developing treatments for cystic fibrosis, hepatitis C, and other diseases of the liver, kidney, and central nervous system.
Priority Engaging
● SB2A temperature range: ≥ 4°C ● Description: Priority Engaging companies face a critical need for environmental improvement. With SB2A indicating a substantial temperature misalignment (≥ 4°C), these companies are recognized as having a very high environmental impact. Priority Engaging companies are urged to prioritize and accelerate their sustainability initiatives to address their significant climate-related challenges.

Rating peers in sector of Health Care (based on 269 companies)

1%
Priority
Enabling
1%
Enabling
1%
Priority
Transitioning
3%
Transitioning
10%
Engaging
VERTEX PHARMACEUTICALS INCORPORATED
84%
Priority
Engaging

Get in touch!

Want to know more? Fill out the form or reach us directly via email at contact@icebergdatalab.com.

France
ICEBERG DATA LAB
39 Avenue Victor Hugo
75116 Paris
📞 +33 1 89 71 64 00
United Kingdom
ICEBERG DATA LAB
1 Fore Street Avenue
EC2Y 9DT London
Germany
ICEBERG DATA LAB
Platz der Einheit 2
60327 Frankfurt am Main, Frankfurt
United States
ICEBERG DATA LAB
100 Cummings Center
Beverly, MA 01915
📞 +1 (351) 235-2879